Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for

Shilpy Dixit1, Joshua P Fessel2, Fiona E Harrison3

  • 1Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA; Graduate Program in Neuroscience, Vanderbilt University, Nashville, Tennessee 37232, USA.

Insights

Early Alzheimer's disease involves mitochondrial dysfunction and oxidative stress. Both amyloid presence and vitamin C deficiency impair mitochondria, suggesting vitamin C as a potential preventative strategy against neurodegeneration.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Mitochondrial dysfunction and oxidative stress are early indicators in Alzheimer's disease (AD).
  • These factors contribute significantly to AD pathology.
  • Understanding early molecular changes is crucial for developing preventative strategies.

Purpose of the Study:

  • To investigate the roles of amyloid-beta and ascorbate (vitamin C) deficiency in early-stage mitochondrial dysfunction in Alzheimer's disease.
  • To explore the impact of these factors on mitochondrial respiration, membrane potential, ATP production, and reactive oxygen species generation.
  • To assess the potential of ascorbate as a preventative measure against AD-related neurodegeneration.

Main Methods:

  • Mitochondria were isolated from young (4-month-old) wild-type mice, APP/PSEN1 transgenic mice, SVCT2+/- mice (impaired vitamin C transport), and combined APP/PSEN1/SVCT2+/- mice.
  • High-resolution respirometry was used to measure oxygen consumption.
  • Mitochondrial membrane potential, ATP/ADP ratio, and reactive oxygen species (ROS) levels were assessed.
  • Acute ascorbate administration was tested on wild-type mitochondria.

Main Results:

  • Mitochondria from SVCT2+/- mice showed reduced oxygen consumption and lower membrane potential.
  • Mitochondria from APP/PSEN1 mice exhibited increased oxygen consumption, elevated membrane potential, but decreased ATP/ADP ratio.
  • Both APP/PSEN1 and SVCT2+/- mitochondria produced higher levels of reactive oxygen species compared to wild-type.
  • Ascorbate administration enhanced oxygen consumption in wild-type mitochondria.

Conclusions:

  • Both amyloid presence and ascorbate deficiency contribute to mitochondrial dysfunction in early Alzheimer's disease, albeit through distinct mechanisms.
  • These dysfunctions manifest as altered energy metabolism and increased oxidative stress.
  • Ascorbate shows potential as a preventative strategy for neurodegenerative diseases, especially in at-risk populations with depleted vitamin C levels.